Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on October 22, 2025

October 22, 2025

CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025

GlobeNewswire

October 22, 2025

Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference

GlobeNewswire

October 22, 2025

Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept Data in Primary Sjögren’s Disease

GlobeNewswire

October 22, 2025

Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025

GlobeNewswire

October 22, 2025

Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time

GlobeNewswire

October 22, 2025

Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors

GlobeNewswire

October 22, 2025

Arvinas to Present Preclinical Data for ARV-806, a PROTAC KRAS G12D Degrader, at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 22, 2025

Applied Food Sciences Partners with Dempsey Corporation to Accelerate Distribution of Innovative Functional Ingredients in Canada

GlobeNewswire

October 22, 2025

Complement 3 Glomerulopathy Market Poised for Phenomenal Expansion at a CAGR of 37.2% During the Forecast Period (2025–2034) Owing to the Launch of Promising Therapies Targeting C3, C5, MASP-3, and RNAi | DelveInsight

GlobeNewswire

October 22, 2025

EmblemHealth Celebrating Strong Leadership in Challenging Times

GlobeNewswire

October 22, 2025

I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025

GlobeNewswire

October 22, 2025

Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor

GlobeNewswire

October 22, 2025

Frontier Medicines Presents Preclinical Data from Three Programs at the 37th AACR-NCI-EORTC International Conference on Molecular Targets

GlobeNewswire

October 22, 2025

Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering

GlobeNewswire

October 22, 2025

Back to Life with Resuscitec’s CARL® Groundbreaking ECPR System – Nominated for the Prix Galien USA 2025 Award

GlobeNewswire

October 22, 2025

ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million

GlobeNewswire

October 22, 2025

La planta de productos farmacéuticos estériles de Curia es nombrada “Fabricante del Año” en Massachusetts

GlobeNewswire

October 22, 2025

Curias Anlage für sterile Arzneimittel als Hersteller des Jahres in Massachusetts ausgezeichnet

GlobeNewswire

October 22, 2025

L'usine de médicaments stériles Curia nommée fabricant de l'année dans le Massachusetts

GlobeNewswire

October 22, 2025

キュリアの無菌製剤施設が、マサチューセッツ州「年間最優秀製造業者」に選出

GlobeNewswire